JUNIOR CARDIOALEX AWARD (JCA)
Be A Part Of Cardioalex 2025 Program
CardioAlex 2025
You are invited to submit your most educational and interesting cases to CardioAlex 2025 Call for Clinical Cases. They will be reviewed and included in a forum session or in the interactive case session.
Submit Your Case In The Following Specialties
Kindly note that your Complications should be submitted to Call for Clinical Cases website, as there will not be a subsequent and specific Call for Complications.
- Intervention
- EPS/AF

Criteria Of Candidates Presenters
- Staff or fellow in a university, military, private or governmental institute.
- Not above 40 years.
- The case should be done by the presenter himself.
Submission Guidelines
Submission process
By submitting your case, you hereby agree presenting it in CardioAlex.
- Clinical Cases will be submitted electronically maximum by 25th of March 2025... Cases sent by email will not be accepted.
- The Case title must not include any trade names (they may, however, be used in the content of your Case).
- No patient, author or institution name should be featured in any part of the Case.
- Please use lower case for the title and text content of your case (capital letters should be used only at the beginning of a sentence, for officially-approved abbreviations and for proper nouns).
- Failing to comply with the above guidelines will disqualify your submission.
- Once the closing date had passed, you will not be able to modify your Case.
- PDF files are only accepted.
- Maximum size allowed for submissions is 10 MB
Selection Process
Submitted cases evaluation will be based on:
- quality
- clarity
- relevance
- educational value for the audience
The CardioAlex Selection Committee will review submissions without access to the authors’ name, institution or country.
Invitation / Notification
The Acceptance Announcement will Start from the 2nd of April 2025
All authors whose submissions are accepted will receive an official invitation from the Organizing Committee with more precise details.